DEFINITIVE CONTRACT
Active75F40126C00070
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$435.2K
obligated · signed 2 months ago
BAA CONTRACT- FY26C2DP2-BEYOND COMPLIANCE: INTEGRATING QUALITY CULTURE AND RISK IN PHARMACEUTICAL QUALITY MANAGEMENT
Performance timeline
Start
Sep 30, 2026
End
Sep 29, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Sep 29, 2027
UNIVERSITAT ST. GALLEN
Contract 75F40126C00070
UEI
LLK6D5M1UAF1
Parent Company
UNIVERSITAT ST. GALLEN
Capabilities & Certifications
Headquarters Location
Current Obligation
$435,179
Base + Exercised Options
$435,179
Total Ceiling Value
$435,179
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS
PSC
GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
Place of Performance
Congressional District: 08
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.